Press Release

Daniel Gruskin, M.D.

Daniel Gruskin was named senior vice president and head of clinical development in August of 2020 after several months working with LogicBio as interim head of clinical development and as a consultant. Previously, Daniel served in roles of increasing responsibility at Sanofi Genzyme, most recently as vice president, head of global medical affairs, rare disease, in which capacity he oversaw medical affairs, life cycle management, scientific affairs and other medical and development activities related to metabolic, rare and/or genetic diseases. Prior to his role at Sanofi Genzyme, Daniel served as assistant professor, human genetics and pediatrics at Emory University School of Medicine, where he was also the chief of the genetics section at Children’s Healthcare of Atlanta.